Skip Navigation

Cardiovascular Research 1994 28(12):1815-1820; doi:10.1093/cvr/28.12.1815
© 1994 by European Society of Cardiology
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brown, S. L
Right arrow Articles by Fujii, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, S. L
Right arrow Articles by Fujii, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1994, European Society of Cardiology

Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis

Steven L Brown, Craig H Lundgren, Thomas Nordt and Satoshi Fujii

Cardiovascular Division, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St Louis, MO 63110, USA: S L Brown, C H Lundgren, T Nordt, S Fujii.

Correspondence to Dr Fujii.

Objective: Migration of smooth muscle cells into the neointima has been implicated in atherogenesis. Vitronectin, a serum factor that promotes cell spreading and attachment, accumulates in atherosclerotic human tissues. The aim of this study was to determine the role of vitronectin and its receptor (integrin {alpha}Vβ3) in migration of smooth muscle cells. Methods: Human aortic smooth muscle cell migration was studied in modified Boyden chambers. Expression of vitronectin receptor was determined by northern blotting of receptor mRNA and immunoprecipitation of receptor protein. Results: Vitronectin dose dependently increased smooth muscle cell migration by an amount comparable to that induced by platelet derived growth factor, (PDGF)-BB. Antiserum to {alpha}Vβ3 diminished vitronectin driven migration. Northern blot analysis showed low constitutive expression of {alpha}V and β3 mRNA by smooth muscle cell and rapid induction with transforming growth factor β (TGF-β) and thrombin. Immunoprecipitation confirmed increased synthesis of the {alpha}Vβ3 vitronectin receptor complex by TGF-β or thrombin. Smooth muscle cells pretreated with TGF-β or thrombin showed increased vitronectin driven migration. cAMP suppressed induction of migration, but inhibition of protein kinase C increased it. Conclusions: These results show that vitronectin-induced human aortic smooth muscle cell migration is mediated by aVB3 vitronectin receptor and expression of the receptor is induced by TGF-β and thrombin, which in turn induce vitronectin driven, vitronectin receptor modulated smooth muscle cell migration.

Cardiovascular Research 1994;28:1815-1820

KEYWORDS integrin; atherogenesis; human aortic smooth muscle cells; vitronectin; migration


This work was supported in part by the National Heart, Lung, and Blood Institutes grant HL- 17646, SCOR in Coronary and Vascular Diseases, and a Grant-in-Aid from the American Heart Association, Missouri Affiliate. The authors wish to thank Dr Burton E Sobel for helpful discussions; Beth Engeszer for editorial assistance: Denise Nachowiak. John Botz. and Jeffrey Labuda for technical assistance; and Barbara Donnelly and Kelly Hall for secretarial assistance.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Wu, L. Peng, G. A. McMahon, D. A. Lawrence, and W. P. Fay
Recombinant Plasminogen Activator Inhibitor-1 Inhibits Intimal Hyperplasia
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1565 - 1570.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Khan, A. Agrotis, and A. Bobik
Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury
Cardiovasc Res, May 1, 2007; 74(2): 223 - 234.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. T. Gerthoffer
Mechanisms of Vascular Smooth Muscle Cell Migration
Circ. Res., March 16, 2007; 100(5): 607 - 621.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Brassard, F. Amiri, G. Thibault, and E. L. Schiffrin
Role of Angiotensin Type-1 and Angiotensin Type-2 Receptors in the Expression of Vascular Integrins in Angiotensin II-Infused Rats
Hypertension, January 1, 2006; 47(1): 122 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bagchi, Z. Liao, F. A. Gonzalez, N. E. Chorna, C. I. Seye, G. A. Weisman, and L. Erb
The P2Y2 Nucleotide Receptor Interacts with {alpha}v Integrins to Activate Go and Induce Cell Migration
J. Biol. Chem., November 25, 2005; 280(47): 39050 - 39057.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. D. Swartz, J. A. Russell, and S. T. Andreadis
Engineering of fibrin-based functional and implantable small-diameter blood vessels
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1451 - H1460.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G.A. Stouffer and S.S. Smyth
Effects of Thrombin on Interactions Between {beta}3-Integrins and Extracellular Matrix in Platelets and Vascular Cells
Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 1971 - 1978.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
U. Kintscher, C. Lyon, S. Wakino, D. Bruemmer, X. Feng, S. Goetze, K. Graf, A. Moustakas, B. Staels, E. Fleck, et al.
PPAR{alpha} Inhibits TGF-{beta}-Induced {beta}5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad4
Circ. Res., November 29, 2002; 91 (11): e35 - e44.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Peng, N. Bhatia, A. C. Parker, Y. Zhu, and W. P. Fay
Endogenous Vitronectin and Plasminogen Activator Inhibitor-1 Promote Neointima Formation in Murine Carotid Arteries
Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. P. Moiseeva
Adhesion receptors of vascular smooth muscle cells and their functions
Cardiovasc Res, December 1, 2001; 52(3): 372 - 386.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. A. Rivera, M. Echegaray, T. Rankinen, L. Perusse, T. Rice, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, et al.
TGF-{beta}1 gene-race interactions for resting and exercise blood pressure in the HERITAGE Family Study
J Appl Physiol, October 1, 2001; 91(4): 1808 - 1813.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. J. A. Chico, J. Chamberlain, J. Gunn, N. Arnold, S. L. Bullens, T. R. Gadek, S. E. Francis, S. Bunting, M. Horton, L. Shepherd, et al.
Effect of Selective or Combined Inhibition of Integrins {{alpha}}IIb{beta}3 and {{alpha}}v{beta}3 on Thrombosis and Neointima After Oversized Porcine Coronary Angioplasty
Circulation, February 27, 2001; 103(8): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. L. Davenpeck, C. Marcinkiewicz, D. Wang, R. Niculescu, Y. Shi, J. L. Martin, and A. Zalewski
Regional Differences in Integrin Expression : Role of {{alpha}}5{beta}1 in Regulating Smooth Muscle Cell Functions
Circ. Res., February 16, 2001; 88(3): 352 - 358.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. H Baron, E. P Moiseeva, D. P de Bono, K. R Abrams, and A. H Gershlick
Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): a possible mechanism for influencing restenosis
Cardiovasc Res, December 1, 2000; 48(3): 464 - 472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Sajid, M. Lele, and G. A. Stouffer
Autocrine thrombospondin partially mediates TGF-beta 1- induced proliferation of vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2159 - H2165.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. T. Eitzman, R. J. Westrick, E. G. Nabel, and D. Ginsburg
Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice
Blood, January 15, 2000; 95(2): 577 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E Stringa, V Knauper, G Murphy, and J Gavrilovic
Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells
J. Cell Sci., January 6, 2000; 113(11): 2055 - 2064.
[Abstract] [PDF]


Home page
HypertensionHome page
S.-i. Hayashi, R. Morishita, H. Matsushita, H. Nakagami, Y. Taniyama, T. Nakamura, M. Aoki, K. Yamamoto, J. Higaki, and T. Ogihara
Cyclic AMP Inhibited Proliferation of Human Aortic Vascular Smooth Muscle Cells, Accompanied by Induction of p53 and p21
Hypertension, January 1, 2000; 35(1): 237 - 243.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. R. Coleman, G. A. Braden, M. C. Willingham, and D. C. Sane
Vitaxin, a Humanized Monoclonal Antibody to the Vitronectin Receptor ({alpha}vß3), Reduces Neointimal Hyperplasia and Total Vessel Area After Balloon Injury in Hypercholesterolemic Rabbits
Circ. Res., June 11, 1999; 84(11): 1268 - 1276.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. C Newby and A. B Zaltsman
Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation
Cardiovasc Res, February 1, 1999; 41(2): 345 - 360.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
T. V. Byzova and E. F. Plow
Activation of {alpha}V{beta}3 on Vascular Cells Controls Recognition of Prothrombin
J. Cell Biol., December 28, 1998; 143(7): 2081 - 2092.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. A. Ellison, J. J. Velier, P. Spera, Z. L. Jonak, X. Wang, F. C. Barone, G. Z. Feuerstein, T. Abumiya, and G. J. del Zoppo
Osteopontin and its Integrin Receptor {alpha}vß3 Are Upregulated During Formation of the Glial Scar After Focal Stroke • Editorial Comment
Stroke, August 1, 1998; 29(8): 1698 - 1707.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Xie, G.F. Clunn, J.S. Lymn, and A.D. Hughes
Role of intracellular calcium ([Ca2+]i) and tyrosine phosphorylation in adhesion of cultured vascular smooth muscle cells to fibrinogen
Cardiovasc Res, August 1, 1998; 39(2): 475 - 484.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Palmer, K. Tsoi, and D. H. Maurice
Synergistic Inhibition of Vascular Smooth Muscle Cell Migration by Phosphodiesterase 3 and Phosphodiesterase 4 Inhibitors
Circ. Res., May 4, 1998; 82(8): 852 - 861.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. A. Stouffer, Z. Hu, M. Sajid, H. Li, G. Jin, M. T. Nakada, S. R. Hanson, and M. S. Runge
ß3 Integrins Are Upregulated After Vascular Injury and Modulate Thrombospondin- and Thrombin-Induced Proliferation of Cultured Smooth Muscle Cells
Circulation, March 10, 1998; 97(9): 907 - 915.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Dufourcq, H. Louis, C. Moreau, D. Daret, M. R. Boisseau, J. M. D. Lamaziere, and J. Bonnet
Vitronectin Expression and Interaction With Receptors in Smooth Muscle Cells From Human Atheromatous Plaque
Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 168 - 176.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
C. Lundgren, B. Vinogradsky, A. Guala, and S. Fujii
A Vitronectin Receptor Antagonist Inhibits Neointimal Formation After Balloon Arterial Injury in Rabbits in Vivo
Vascular and Endovascular Surgery, January 1, 1998; 32(1): 47 - 53.
[Abstract] [PDF]


Home page
BloodHome page
C. C. Wilhide, Y. Jin, Q. Guo, L. Li, S.-X. Li, E. Rubin, and P. F. Bray
The Human Integrin beta 3 Gene Is 63 kb and Contains a 5'-UTR Sequence Regulating Expression
Blood, November 15, 1997; 90(10): 3951 - 3961.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Cambien, S. Ricard, A. Troesch, C. Mallet, L. Generenaz, A. Evans, D. Arveiler, G. Luc, J.-B. Ruidavets, and O. Poirier
Polymorphisms of the Transforming Growth Factor-ß1 Gene in Relation to Myocardial Infarction and Blood Pressure: The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study
Hypertension, November 1, 1996; 28(5): 881 - 887.
[Abstract] [Full Text]


Home page
CirculationHome page
O. Shpilberg, I. Rabi, K. Schiller, R. Walden, D. Harats, K.S. Tyrrell, B. Coller, and U. Seligsohn
Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein {alpha}IIb{beta}3 (GPIIb/IIIa) and {alpha}v{beta}3 Receptors Are Not Protected From Atherosclerosis
Circulation, March 5, 2002; 105(9): 1044 - 1048.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.